Background Previous trials suggest lower long-term risk of mortality after invasive rather
than non-invasive management of patients with non-ST elevation myocardial infarction (NSTEMI…

Objective To determine the relation between age and troponin level and its prognostic
implication. Design Retrospective cohort study. Setting Five cardiovascular centres in the UK …

Background There is limited evidence on the use of high-sensitivity C-reactive protein (hsCRP)
as a biomarker for selecting patients for advanced cardiovascular (CV) therapies in the …

Population-level biomedical research has become crucial to the health system’s ability to
improve the health of the population. This form of research raises a number of well-…

Background Patients presenting with atrial fibrillation ( AF ) often undergo a blood test to
measure troponin, but interpretation of the result is impeded by uncertainty about its clinical …

Background Current clinical guidelines recommend treating chronic hepatitis B virus (HBV)
infection in a minority of cases, but there are relatively scarce data on evolution or …

Chronic infection with hepatitis B virus (HBV) is a global health problem, resulting in an
estimated 887000 deaths worldwide in 2015. 1 Unlike deaths from other infections such as …

HBsAg and HBeAg have gained traction as biomarkers of control and clearance during chronic
hepatitis B virus infection (CHB). Improved understanding of the clearance correlates of …

Evidence generated from randomized controlled trials forms the foundation of cardiovascular
therapeutics and has led to the adoption of numerous drugs and devices that prolong …

The association of liver biochemistry with clinical outcomes of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) infection is currently unclear, and the utility of …